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Abstract 
Cylindrospermopsin (CYN) is an alkaloid biosynthesized by selected cyanobacteria, the 
cyto- and genotoxic properties of which have been studied extensively by in vitro and in vivo 
experimental models. Various studies have separately established the role of uracil, 
guanidine and hydroxyl groups in CYN-induced toxicity. In the present study, we have 
prepared five synthetic analogues that all possess a uracil group but had variations in the 
other functionality found in CYN. We compared the in vitro toxicity of these analogues in 
common carp hepatocytes by assessing oxidative stress markers, DNA fragmentation and 
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apoptosis. All the analogues tested induced generation of reactive oxygen species, lipid 
peroxidation (LPO) and DNA fragmentation. However, the greatest increase in LPO and 
increase in caspase-3 activity, an apoptosis marker, was demonstrated by an analogue 
containing guanidine, hydroxyl and uracil functionalities similar to those found in CYN but 
lacking the complex tricyclic structure of CYN. We also report a crystal structure of an 
analogue lacking the hydroxyl group found in CYN which does not show intramolecular H-
bonding interactions between the guanidine and the uracil functionalities. The observations 
made in this work supports the hypothesis that CYN toxicity is a result of an interplay 
between both of the uracil, hydroxyl and guanidine functional groups.  
 
Keywords: cylindrospermopsin; cyanobacteria; mechanism of action; hepatocytes; oxidative 
stress; DNA damage 
 
1. Introduction 
Cylindrospermopsin (CYN) 1 is a polyketide-derived alkaloid with a central functional 
guanidino-moiety combined with hydroxymethyluracil attached to its tricyclic carbon 
skeleton and is synthesized by a number of cyanobacterial species associated with the surface 
waters of Australia and New Zealand, Antarctica, Asia, South and North America and Europe 
(Rzymski and Poniedziałek 2014). Since CYN structure was first isolated from Raphidiopsis 
(formerly Cylindrospermopsis) raciborskii by Ohtani et al. (1992), it has been subject to 
extensive research on its potential ecological role (Rzymski et al. 2014; Dobronoki et al. 
2018) and toxicity in eukaryotic organisms (Poniedziałek et al. 2012; Pichardo et al. 2017). 
Due to its in vivo metabolism, the toxin primarily targets liver and kidneys, but due to its 
generalized cytotoxicity it can also affect other organs (e.g., eye, spleen, lungs, thymus, 
heart). It can also impact the immune system cells and lead to alteration of different immune 
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functions (Terao et al. 1994; Seawright et al. 1999; Poniedziałek et al. 2014a). As 
retrospectively suggested, CYN presence in the local water led to hospitalization of 148 
people, the vast majority children, during the outbreak in 1979 (Byth 1980).  
As shown, CYN displays a wide range of  adverse cyto- and genotoxic effects 
encompassing generation of reactive oxygen species above the antioxidant cell capacity 
marked not only by consumption of catalase and superoxide dismutase but also by 
simultaneous inhibition of glutathione synthesis (Runnegar et al. 1995; Poniedziałek et al. 
2015), irreversible protein synthesis inhibition (Terao et al. 1994), lipid peroxidation, 
genotoxicity manifested by DNA double-strand breaks and increased frequencies of 
micronucleus, nuclear buds and nucleoplasmic bridge formation (Straser et al. 2011), cell-
cycle arrest and induction of necrosis and apoptosis (Lankof et al. 2007; Poniedziałek et al. 
2014; Poniedziałek et al. 2015). It is plausible that these effects are all related, influence each 
other and result from CYN metabolism. However, genes encoding cytochrome P450 enzymes 
were shown to be upregulated following the CYN exposure, no direct evidence for phase I 
was found so far while phase II biotransformation was not studied (Kittler et al. 2016). 
Elucidating which structures of CYN are pivotal for its toxicity may be helpful in further 
understanding its metabolism and associated cellular effects.   
Four structurally similar compounds to CYN 1 have also been isolated from 
cyanobacteria; 7-epi-cylindrospermopsin 2 (Banker et al. 2000), 7-deoxy-cylindrospermopsin 
3 (Norris et al. 1999), 7-deoxy-desulfo-cylindrospermopsin 4 and 7-deoxy-desulfo-12-
acetylcylindrospermopsin 5 (Wimmer et al. 2014), and research aimed to elucidate the 
potential role of various structural features of CYN 1 in its toxicity has been performed 
(Evans and Murphy 2011a). As already established, the exact stereochemistry of the hydroxyl 
group at C-7 or the presence of the sulfate group had no significant effect in this regard, 
however the hydroxyl group appears to be essential for activity (Evans and Murphy 2011). It 
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has similarly been postulated, that the uracil ring is pivotal in the expression of the biological 
activity of CYN 1 (Runnegar et al. 2002) (Figure 1(ii)). Our previous work in this area 
concentrated on the preparation of a series of simplified analogues 11a-c of CYN 1 in which 
the tricyclic moiety is missing and a pendant chain attaches the guanidinium portion of the 
molecule to the hydroxymethyluracil function. The tricyclic analogue 12 was also prepared 
which lacked the sulfate and hydroxyl functionality found in CYN 1 (Cartmell et al. 2017). 
We observed by comparison of bioactivity of the synthetic analogues that only those with a 
hydroxyl group at C-7 produced significant toxicity in human cells. The greatest toxicity was 
revealed by compound 11c, which possess a 6-carbon tether separating the guanidine and 
uracil groups. This tether length might allow the compound to adopt a similar conformation to 
that of CYN 1 as might a 4-carbon tether as compound 11a had similar activity. A tether 
length of 5-carbons (11b) revealed a significantly decreased bioactivity. These studies appear 
to highlight the profound role of the hydroxyl group at C-7 in uptake and toxicity and the 
lower activity of 11b might suggest that conformational effects in the analogues might also be 
a key factor (Cartmell et al. 2017) (Figure 1(ii)). This work gave a clear correlation between 
the presence of the guanidine, uracil and hydroxyl groups and the levels of activity (Cartmell 
et al. 2017). We wished to investigate the activity further and sought to prepare analogues in 
which each of these functional groups, with the exception of the uracil, was eliminated or 
modified. We thus sought to prepare the following analogues; compound 13, which lacks the 
hydroxyl and guanidine function, compound 14, which lacks the hydroxyl function only and 
compound 15, which lacks the guanidine function only. Where the guanine function is 
lacking, it was replaced with the amine functional group, as this should mimic the cationic 
nature of the guanidine (Figure 1(iii). In order to test the toxicity of these compounds, an in 
vitro experimental model using hepatocytes isolated from healthy Cyprinus carpio was 
employed. 
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Figure 1. (i) The cylindrospermopsin alkaloids 1-5. (ii) The previously prepared analogues 
11a-c (n = 1-3) and 12. (iii) New analogues 13-15 prepared in this study 
 
 
 
2. Materials and Methods  
2.1. Synthesis 
 Detailed information on starting materials, compound visualization and instruments 
employed in analogue synthesis are given in the Supplementary Material.  
 
6 
 
2.1.1. (E/Z)-6-(2,6-dimethoxypyrimidin-4-yl)hex-5-en-1-ol 18 
To a stirred suspension of phosphonium salt 17 (499.7 mg, 1.43 mmol) in anhydrous THF 
(20 mL) was added n-BuLi (1.14 mL, 2.86 mmol), after 1 h aldehyde 16 (240.4 mg, 1.43 
mmol) in anhydrous THF (10 mL) was added drop-wise over 5 minutes. Reaction progress 
was monitored via TLC and after 2 h the reaction was quenched with NH4Cl (sat. 5 mL), 
diluted with water (5 mL) and extracted with EA (3 x 25 mL). The combined organic extracts 
where then dried over anhydrous MgSO4 and the solvent removed under reduced pressure. 
After evaporation, purification by flash column chromatography on silica gel using ethyl 
acetate in petroleum ether stepwise gradient of 25:75 to 50:50) gave 18 (0.29 g, 1.22 mmol, 
85%, E/Z ratio 47:53) as a clear oil, which was used without further purification. Rf 0.15 
(40% ethyl acetate in petroleum ether); vmax 3368, 2935, 2862, 1644, 1586, 1556, 1477, 1458, 
1373, 1354, 1338, 1203; (E)-6-(2,6-dimethoxypyrimidin-4-yl)hex-5-en-1-ol δH 1.54-1.67 
(4H, m, 2 x CH2), 2.26-2.31 (2H, m, CH2), 3.67 (2H, t, J 6.2 Hz, CH2), 3.95 (3H, s, CH3), 
4.00 (3H, s, CH3), 6.18 (1H, s, CH), 6.29 (1H, d, J 15.2 Hz, CH), 7.01 (1H, dt, J 15.2, 7.2 Hz, 
CH); δC 25.6, 29.0, 32.3, 53.7, 54.7, 62.6, 98.3, 128.0, 139.7, 164.5, 165.2, 172.3; m/z (ESI) 
499.3 (13%, [2M+Na]
+
), 261.1 (30%, [M+Na]
+
), 239.1 (100%, [M+H]
+
); HRMS (ESI) found 
239.1392 ([M+H]
+
), C12H19O3N2 requires 239.1390. (Z)-6-(2,6-dimethoxypyrimidin-4-yl) 
hex-5-en-1-ol δH 1.53-1.67 (4H, m, 2 x CH2), 1.72 (1H, br s, OH), 2.76-2.81 (2H, m, CH2), 
3.66 (2H, t, J 6.1 Hz, CH2), 3.95 (3H, s, CH3), 3.98 (3H, s, CH3), 5.98 (1H, dt, J 11.6, 7.6 Hz, 
CH), 6.19-6.22 (1H, m, CH), 6.22 (1H, s, CH); 3.96 (3H, s, CH3), 4.02 (3H, s, CH3), 4.06 
(3H, s, CH3) 7.06 (1H, s, CH); δC 25.6, 29.0, 32.3, 53.7, 54.7, 62.7, 101.1, 126.6, 141.4, 
165.2, 172.2 (1 x C not observed); m/z (ESI) 499.3 (16%, [2M+Na]
+
), 261.1 (35%, [M+Na]
+
), 
239.1 (100%, [M+H]
+
); HRMS (ESI) found 239.1392 ([M+H]
+
), C12H19O3N2 requires 
239.1390. 
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2.1.2. 6-(2,6-dimethoxypyrimidin-4-yl)hexan-1-ol 19 
Palladium on charcoal (10%, 100 mg) was added to a solution of alkene 18 (979.6 mg, 
4.11 mmol) in EA (20 mL) and the mixture stirred vigorously under a hydrogen atmosphere 
for 24 h. The reaction mixture was the filtered through a plug of celite® and the filter pad 
washed with ethyl acetate (3 x 50 mL), the combined organic extracts where then dried over 
anhydrous MgSO4 and the solvent removed under reduced pressure. After evaporation, 
purification by flash column chromatography on silica gel using diethyl ether in petroleum 
ether (stepwise gradient of 40:60 to 60:40) gave 19 as a clear oil (587.2 mg, 2.44 mmol, 59 
%). Rf 0.19 (80% diethyl ether in petroleum ether); vmax 3368, 2988, 2934, 2860, 1595, 1567, 
1482, 1459, 1385, 1358, 1206; δH 1.32-1.43 (4H, m, 2 x CH2), 1.49 (1H, br s, OH), 1.53-1.60 
(2H, m, CH2), 1.67-1.74 (2H, m, CH2), 2.59 (2H, t, J 7.8 Hz, CH2), 3.64 (2H, t, J 6.6 Hz, 
CH2), 3.94 (3H, s, CH3), 3.97 (3H, s, CH3), 6.19 (1H, s, CH); δC 25.4, 28.3, 28.9, 32.6, 37.3, 
53.6, 54.5, 62.8, 99.5, 165.2, 171.8, 173.0; m/z (ESI) 503.3 (18%, [2M+Na]
+
), 263.1 (15%, 
[M+Na]
+
), 241.2 (100%, [M+H]
+
); HRMS (ESI) found 241.1547 ([M+H]
+
), C12H21O3N2 
requires 241.1547. 
 
2.1.3. 6-(2,6-dimethoxypyrimidin-4-yl)hexan-1-amine 20 
To a cooled (0 °C) and stirred solution of alcohol 19 (294.0 mg, 1.22 mmol), 
triphenylphosphine (673.8 mg, 2.57 mmol) and phthalimide (450.1 mg, 3.06 mmol) in 
anhydrous THF (10 mL) was added diisopropyl azodicarboxylate (DIAD, 0.51 mL, 2.57 
mmol) and the mixture allowed to stir and warm to rt over 48 h. The solvent was removed 
under reduced pressure and the residue dissolved in EtOH (15 mL), ethylenediamine (0.82 
mL, 12.23 mmol) was added and the mixture heated at reflux for 24 h. The resulting 
precipitate was removed by filtration through a plug of celite® and the filter pad washed with 
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EtOH (3 x 10 mL); the combined organic extracts where then dried over anhydrous MgSO4 
and the solvent removed under reduced pressure. After evaporation, purification by flash 
column chromatography on silica gel (methanol in ethyl acetate stepwise gradient of 0:100 to 
5:95 containing 1% NH3 (aq. conc.)) gave 20 (242.9 mg, 1.02 mmol, 83%) as a clear oil. Rf 
0.11 (10% methanol in ethyl acetate, 1% NH3 (aq.)); vmax 3400, 2932, 2859, 1596, 1566, 
1481, 1459, 1385, 1357, 1206; δH 1.33-1.40 (4H, m, 2 x CH2), 1.44-1.52 (2H, m, CH2), 1.64-
1.73 (2H, m, CH2), 2.58 (2H, t, J 7.6 Hz, CH2), 2.64 (2H, t, J 7.2 Hz, CH2), 3.95 (3H, s, CH3), 
3.97 (3H, s, CH3), 6.31 (1H, s, CH); δC 27.7, 29.7, 30.1, 33.6, 38.0, 42.5, 54.4, 55.1, 100.3, 
166.7, 173.6, 174.7; m/z (ESI) 479.3 (12%, [2M+H]
+
), 240.2 (100%, [M+H]
+
); HRMS (ESI) 
found 240.1706 ([M+H]
+
), C12H22O2N3 requires 240.1707. 
 
2.1.4. 6-(6-aminohexyl)pyrimidine-2,4(1H,3H)-dione hydrochloride 13 
A solution of pyrimidine 20 (60.6 mg, 0.253 mmol) in HCl (2 M, 3 mL) was heated to 
100 °C. Reaction progress was monitored via TLC and after 36 h the reaction mixture was 
evaporated to dryness under reduced pressure and the residue obtained dried under vacuum 
over P2O5. After dissolving the residue in methanol (9 mL), containing 3 drops of HCl (12 
M), diethyl ether (ca. 2 mL) was added until the cloud point. After cooling (-20 °C) overnight, 
compound 13 (54.4 mg, 0.220 mmol, 87%) was obtained as an off-white solid. M.p. 256 °C 
(decomp.); vmax 2920, 2852, 2808, 1708, 1657, 1600, 1502, 1463, 1419, 1356, 1227; δH 1.33-
1.42 (4H, m, 2 x CH2), 1.57-1.68 (2H, m, 2 x CH2), 2.45 (2H, t, J 7.6 Hz, CH2), 2.97 (2H, t, J 
7.6 Hz, CH2), 5.63 (1H, s, CH); δC 25.2, 26.3, 26.5, 27.3, 31.9, 39.4, 98.7, 153.1, 159.5, 
167.4; m/z (ESI) 212.1 (100%, [M+H]
+
); HRMS (ESI) found 212.1394 ([M+H]
+
), 
C12H18O2N3 requires 212.1394. 
 
2.1.5. 1-(6-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)hexyl)guanidine hydrochloride 14 
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1H-Pyrazole-1-carboxamidine hydrochloride (61.1 mg, 0.417 mmol) was added to a 
solution of the amine salt 13 (36.4 mg, 0.147 mmol) and N,N-diisopropylethylamine (DIPEA, 
72.0 μL, 0.42 mmol) in anhydrous DMF (5 mL) and the mixture stirred at rt for 48 h. The 
dimethylformamide (DMF, 5 mL) was removed by azeotropic evaporation with heptane (4 x 
15 mL) and the residue dried under high vacuum for 4 h. The resulting material was then 
stirred with diethyl ether (10 mL) for 16 h, the solvent decanted and the insoluble residue 
dissolved in water (5 mL) which was passed through a small plug of celite® (pipette) and the 
water evaporated under reduced pressure. Purification was achieved by slow crystallization 
from methanol/diethyl ether (2:3, 5 mL) containing one drop of HCl (12 M), giving 14.2H2O 
(24.1 mg, 0.074 mmol, 50 %) as off-white crystals. M.p. 221-223 °C; vmax 3337, 3174, 2934, 
2856, 1628, 1613, 1500, 1415, 1358, 1236; δH 1.37-1.46 (4H, m, 2 x CH2), 1.55-1.71 (4H, m, 
2 x CH2), 2.41 (2H, t, J 7.6 Hz, CH2), 3.18 (2H, t, J 7.0 Hz, CH2), 5.46 (1H, s, CH); δC 27.3, 
28.4, 29.7, 33.4, 42.4, 99.4, 153.6, 158.6, 159.3, 167.4; m/z (ESI) 254.2 (100%, [M+H]
+
); 
HRMS (ESI) found 254.1613 ([M+H]
+
), C12H18O2N3 requires 254.1612. 
 
2.1.7. 4-azido-1-(2,6-dimethoxypyrimidin-4-yl)butyl acetate 22 
A solution of the previously prepared alcohol 21 (Evans et al. 2014), 140.5 mg, 0.520 
mmol), PPh3 (286.4 mg, 1.092 mmol) and DIAD (215 μL, 1.092 mmol) in anhydrous THF 
(10 mL) was cooled to -5 °C and stirred for 15 min. Diphenylphosphoryl azide (280 μL, 1.300 
mmol) was added and the mixture stirred to rt over 16 h. After evaporation, purification by 
flash column chromatography on silica gel (diethyl ether in petroleum ether, stepwise gradient 
of 10:90 to 40:60) gave azide 22 (128.8 mg, 0.437 mmol, 84 %) as a clear oil. Rf 0.33 (60% 
diethyl ether in petroleum ether; vmax 2958, 2105, 1738, 1594, 1572, 1483, 1461, 1386, 1358, 
1241, 1205; δH 1.64-1.80 (2H, m, CH2), 1.86-2.01 (2H, m, CH2), 2.03 (3H, s, CH3), 3.97 (3H, 
s, CH3), 3.99 (3H, s, CH3), 4.08 (2H, t, J 6.0 Hz, CH2), 4.24 (1H, dd, J 6.0, 7.2 Hz, CH), 6.37 
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(1H, s, CH); δC 20.9, 25.0, 30.2, 54.0, 54.9, 63.7, 64.5, 98.7, 165.5, 169.1, 171.0, 172.4; m/z 
(ESI) 318.1 (12%, [M+Na]
+
), 296.1 (100%, [M+H]
+
); HRMS (ESI) found 296.1353 
([M+H]
+
), C12H18O4N5 requires 296.1353. 
 
2.1.8. 6-(4-amino-1-hydroxybutyl)pyrimidine-2,4(1H,3H)-dione hydrochloride 15 
A solution of azide 22 (92.6 mg, 0.315 mmol) in HCl (2M, 19 mL) was heated to 100 
°C. Progress of the reaction was monitored (TLC) and after 16 h the mixture was evaporated 
under reduced pressure and the residue dried under vacuum over P2O5. The residue was then 
dissolved in THF:H2O (4:1, 7 mL) and cooled to 0 °C. PPh3 (123.9 mg, 0.475 mmol) was 
added and the mixture was stirred to rt over 48 h. The reaction mixture was evaporated to 
dryness, triturated with water (2 x 2 mL) and the triturates filtered through a thin pad of 
Celite© (pipette) then evaporated under reduced pressure. The residue was dissolved in 
methanol (5 mL) containing 3 drops of HCl (12 M) and DE (ca. 2 mL) was added until the 
cloud point. After cooling (-20 °C) overnight, 15 (27.1 mg, 0.115 mmol, 37 %) was obtained 
as an off-white solid. M.p. 228-230 °C; vmax 3095, 3033, 2956, 2883, 2779, 1681, 1606, 1495, 
1445, 1398, 1380, 1326, 1286, 1258, 1244; δH 1.61-1.69 (2H, m, CH2), 2.02 (2H, ddd, J 2.4, 
7.2, 10.0 Hz, CH2), 3.64 (2H, td, J 5.9, 1.8 Hz, CH2), 4.09 (1H, t, J 7.2 Hz, CH), 5.72 (1H, s, 
CH); δC 28.9, 31.0, 52.6, 79.5, 99.4, 152.7, 153.7, 166.3; m/z (ESI) 797.4 (6%, [4M+H]
+
), 
620.3 (12%, [3M+Na]
+
), 598.3 (24%, [3M+H]
+
), 399.2 (40%, [2M+H]
+
), 200.1 (100%, 
[M+H]
+
); HRMS (ESI) found 200.1027 ([M+H]
+
), C8H14O3N3 requires 200.1030. 
 
2.2. Toxicological studies 
2.2.1. Experimental design 
The toxicity of synthesized variants of CYN was compared in hepatocytes isolated from 
common carp Cyprinus carpio. This model has been chosen as previous studies have 
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demonstrated that cyanobacterial compounds can target hepatocytes and that CYN can cause 
cell damage and oxidative stress specifically in fish hepatocytes (Gutiérrez-Praena et al. 2011; 
Falfushynska et al. 2019).  
Hepatocytes were isolated by digestion in 100 µL of 0.1% trypsin/EDTA for 2 min. The 
reaction was terminated by Dulbecco’s modified Eagle medium (1:3 v/v) supplemented with 
20% fetal calf serum (Burdon and van Knippenberg, 1991, Grunow et al., 2011). The viability 
of Percoll-purified cells was evaluated using trypan blue exclusion test. Hepatocytes yield 
was in the range of 50-80×10
6
 g
-1
 liver and cell viability was higher than 82%. Purified 
suspensions of the freshly isolated carp hepatocytes were resuspended in Hank’s balanced salt 
solution without Ca
2+
 and Mg
2+
 at a density of 10
7
 cells mL
-1
. Cells were seeded in 24-well 
plates and allowed to attach. In each experiment cells (10
7
 cells per mL) were exposed to 10 
µg mL
-1
 of each analogue for 2 h at 20 °C. The control was constituted of cells unexposed to 
any analogue. At the end of the exposure, the isolated hepatocytes were washed in 
physiological saline, re-suspended with trypsin and kept for further analysis. Selected 
parameters related to oxidative stress (lipid peroxidation, protein carbonyl, catalase activity), 
genotoxicity and apoptosis were tested. The results were standardized over the protein content 
determined in whole cell lysates using the Lowry protein assay (Lowry et al. 1951). Each 
assay was performed on 8 independent cell cultures of cells with each cell culture prepared 
from individual fish. 
 
2.2.2. Oxidative stress 
 Immediately after exposure, hepatocytes pellet was re-suspended in 20 mM HEPES 
reached with 0.32 М sucrose and centrifuged at 12000 ×g for 45 min at 4°C. The formation of 
reactive oxygen species (ROS) were determined in supernatant using dihydrorhodamine 
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(Viarengo et al. 1974) with fluorescence measured by an f-max [Ex/Em = 485/538 nm] at 0 
and after 20 min. The rates of ROS generation were than calculated from these two values. 
 Exposed hepatocytes were re-suspended in 50 mM PBS (1/10 w/v) and centrifuged at 
3000×g for 5 min at 4°C. Activity of catalase (CAT, EC 1.11.1.6) was evaluated in an aliquot 
of soluble fraction that contained approx. 150 μg of proteins by the decomposition of 10 mM 
H2O2 according to Aebi (1974) at 240 nm (ε = 40 M
−1 cm-1) in the 50 mM KH2PO4 (pH 7.0) 
medium. 
 Lipid peroxidation (LPO) was evaluated by the production of TBA-reactive substances 
(TBARS) in a supernatant of isolated cell pellet. For that reason, isolated hepatocytes were re-
suspended in 50 mM PBS (1/10 w/v) and proteins precipitated with 30% trichloroacetic acid 
(30%). The absorbance of the final product was determined at 532 nm. A molar extinction 
coefficient of 1.56•105 M−1 cm−1 was used. Results were expressed as pmol TBARS mg-1 
protein. 
 Protein carbonyl (PC) concentration was evaluated in the pellet of the trichloroacetic 
acid-treated isolated cells by the reaction with 2,4-dinitrophenylhydrazine (DNPH) (Reznick 
and Packer 1994). Differences in the absorbance between the DNPH- and the HCl-treated 
samples were determined spectrophotometrically (370 nm), with the amount of carbonyls 
determined by using a molar extinction coefficient of 2.2•104 M−1 cm−1. Results were 
expressed as nmol PC mg
−1
 protein. 
 
2.2.3. DNA fragmentation 
 Fragmentation of damage was evaluated in treated cells lysates in the mixture of 2% 
SDS, 10 mM EDTA, 40 mM NaOH and 10 mM Tris by the levels of protein-free DNA strand 
breaks by the alkaline DNA precipitation assay (Falfushynska et al. 2017) using Hoechst 
33,342. The assay was performed in the presence of 0.4 M NaCl, 4 mM sodium cholate, and 
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0.1 M Tris (pH 9) to minimize the potential interference with traces of sodium dodecyl 
sulphate. The fluorescence was detected by an f-max (Ex/Em = 360/450 nm). 
2.2.4. Apoptosis 
Induction of apoptosis was evaluated by measuring the activity of  caspase-3. The assay 
was based on the hydrolysis of peptide acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-
pNA) by caspase-3 that lead to formation of p-nitroaniline (Falfushynska et al. 2014). Briefly, 
treated hepatocytes were lysed by the addition of chilled cell lysis buffer containing 10 mM 
HEPES, pH 7.4, 2 mM EDTA, 0.1% CHAPS, 5 mM PMSF and 5 mM β-mercaptoethanol. 
Cell were incubated on ice for 10 minutes, homogenized and then centrifuged to remove the 
debris. Each sample was then incubated with Ac-DEVD-pNA for 1 h at 20°C. The absorbance 
was measured at 405 nm. 
 
2.2.5. Statistical analyses 
The statistical analyses were conducted using the Statistica 12.0 (StatSoft, United States). All 
data were normally distributed (tested with Levene test), and if Gaussian assumption was not 
met they were normalized by the Box-Cox transforming method. The effects of analogues on 
particular parameters were compared with one-way ANOVA with the Tukey HSD post-hoc 
test. p < 0.05 was considered as statistically significant. Normally distributed data were 
subjected to the principal component analysis (PCA) to disclose the putative biomarker 
signatures of studied exposures. 
 
3. Results and Discussion 
3.1. Synthesis 
The synthesis used a new methodology to access the three required analogs. Firstly the 
known aldehyde 16 (Cartmell et al. 2017) was reacted with the ylide prepared from the 
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phosphonium salt 17 (Meyer and Collington 1971) to give the alkene 18 as a 47:53 mix of 
E:Z isomers in 85% yield (Figure 2). Hydrogenation over Pd/C was achieved in 59 % yield to 
give 19, which was converted to the amine 20 over two steps (Phthalimide/PPh3/DIAD then 
ethylenediamine) in 83% Yield. Finally, hydrolysis of the 2,4-dimethoxypyrimidine using 
hydrochloric acid (2 M) gave the required amine 13 as its hydrochloride salt in 87% yield. 
Guanidinylation of 13 using 1H-Pyrazole-1-carboxamidine hydrochloride gave the required 
guanidine 14 in 56% after purification. Analogue 15 was prepared from the previously 
prepared alcohol 21 (Cartmell et al. 2017) using a similar strategy to that above. Alcohol 21 
was firstly converted into the azide 22 using PPh3, DIAD and diphenylphosphoryl azide 
(DPPA) in 84% yield. This was followed by hydrolysis of the 2,4-dimethoxypyrimidine and 
acetate groups in hydrochloric acid (2 M) and conversion of the azide functionality to the 
amine under Staudinger conditions to give 15 as a hydrochloride salt in 37% yield over 2 
steps (Figure 2). 
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Figure 2. Synthesis of the analogues 13, 14 and 15: (i) (a) 17, nBuLi, THF, 1 h. (b) 16, 
THF, 2 h, 85%; (ii) H2, Pd/C, EA, 24 h, 59%; (iii) (a) Phthalimide, PPh3, DIAD, THF, 48 
h. (b) H2N(CH2)2NH2, EtOH, 24 h, 83% (over 2 steps); (iv) HCl (2 M), 100 °C, 36 h, 
87%; (v) 1H-Pyrazole-1-carboxamidine hydrochloride, DIPEA, DMF, 48 h, 50%; (vi) 
(a) PPh3, DIAD, THF, -5 °C, 15 min. (b) DPPA, -5 °C - rt, 16 h, 84%; (vii) (a) HCl (2 M), 
100 °C, 16h. (b). PPh3, THF:H2O (4:1), 0 °C - rt, 48 h, 37% (over 2 steps). 
3.2. Toxicological activity 
Various studies have suggested that a given feature or features of the CYN 1 molecule, 
namely the uracil, the guanidinium ion or the hydroxyl group might be crucial for the toxicity 
of this cyanotoxin (Banker et al. 2001; Runnegar et al. 2002; Cartmell et al. 2017). As 
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previously shown, compound 11a that contained all three motifs, displayed comparable 
toxicity to that of naturally occurring CYN 1, whilst the lack of the hydroxyl group in a more 
closely related structural analogue 12 significantly decreased the activity (Cartmell et al. 
2017). As suggested, the hydroxyl group may increase CYN 1 reactivity due to the 
availability for hydrogen bond donors, or it may be involved in transport across the plasma 
membrane, e.g. via insertion of hydroxyl group into hydrophilic phospholipid head group, 
similarly to cholesterol (Cooper 2002). In the present work, the synthesis of specific CYN 
analogues allowed the comparison of guanidine and hydroxyl groups as potential active 
agents by employing an in vitro experimental model using hepatocytes isolated from Cyprinus 
carpio. This model was employed as previous studies have demonstrated that CYN can cause 
cell damage and oxidative stress in fish hepatocytes (Gutiérrez-Praena et al. 2011). 
As found, all the CYN analogues tested (13-15, 11a and 11c) caused an increase in 
cellular ROS, lipid peroxidation and protein carbonylation, indicating an onset of oxidative 
stress (Figure 5). This indicates that all compounds can cross a cellular membrane, and 
despite previous assumptions, hydroxyl and guanidine groups may not be pivotal for this 
process, at least in hepatocytes. The greatest increase in lipid peroxidation and protein 
carbonylation was observed after exposure of hepatocytes to 11c and 11a, respectively. From 
the set of tested compounds, these two resemble naturally occurring CYN the most. 
Considering the differences in cellular response observed after treatment with the different 
analogues, it is possible to conclude that hydroxyl and guanidine groups have complimentary 
roles in the toxicity expressed by CYN. All compounds caused a similar increase in DNA 
fragmentation although only 11a and 11c induced an increase in caspase-3 activity, a marker 
of apoptosis that is known to be involved in CYN-mediated toxicity (Poniedziałek et al. 2014; 
López-Alonso et al. 2013; Poniedziałek et al. 2015).  
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Figure 5. Generation of intracellular ROS (A), catalase activity (B), lipid peroxidation (C), 
protein carbonylation (D), DNA strand break (E) and caspase-3 activity (F) in fish 
hepatocytes (n=8) after 2 h exposure to different CYN analogues (data presented as 
mean±SD). Different superscripts denote significant (p < 0.05) differences between 
investigated analogues according to post-hoc Tukey's HDS test (ANOVA). 
 
In general, analogue 14 (containing guanidine but lacking a hydroxyl group) caused the 
lowest increase in concentration of reactive oxygen species, and contrary to other compounds 
it did not increase CAT level. As revealed by Principal Cluster Analysis, the effects revealed 
by analogue 14) created a conjoin group with control along the PC2 axis, while all other 
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effects induced by other analogues formed relatively tight clusters located on the opposite site 
(Figure 6). This is in line with previous findings by Cartmell et al. (2017) in which a synthetic 
analogue 12 and naturally occurring deoxy-CYN 3, both closely resembling CYN but lacking 
the hydroxyl group also displayed low activities. Similarly, the naturally occurring deoxy-
CYN 3, has significantly lower toxicity again presumed due to lack of the hydroxyl-function.  
Compound 15 (lacking guanidine) and 13 (lacking hydroxyl and guanidine) caused a 
similar response in various tests although 15 had a greater effect on increase in lipid 
peroxidation. This might indicate that the protonated amine is an effective surrogate for the 
protonated guanidine and the presence of a positively charged ion at this part of the molecule 
is a requirement for activity as has been observed in other synthetic analogues (Runnegar et 
al. 2002). The highest increase in this parameter was however, found after exposure to 11c 
(Figure 6). It thus appears that both the guanidine and hydroxyl groups have a role in CYN 1 
toxicity, and the interplay of both these groups is responsible for the overall cellular effect of 
this cyanotoxin. The presence of an allylic hydroxyl group may offer the possibility for the 
formation of hydroxyl radicals, a process that is involved in lipid peroxidation via hydrogen 
radical abstraction followed by O2 addition (Tejero et al. 2007). 
One should note that this applied the same mass concentration of each analogue and due 
to the difference in their molecular weight, the molar concentrations to which cells were 
exposed slightly vary. However, the hypothesis that increased number of molecules may 
increase the toxic effects is not justified as analogue 11c with the lowest molecular weight 
revealed to be most potent in some assays. 
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Figure 6. Principal component analysis for all studied biological traits in fish hepatocytes 
after 2 h exposure to different CYN 1 analogues (13-15, 11a, 11c) and control (C). 
It is possible that guanidine related NH group(s), the hydroxyl and the uracil, which are 
proximal in the molecules studied, might interact via intramolecular hydrogen bonding and 
these functional groups have the ability to form specific interactions with their biomolecular 
targets.  Potentially this may favour a decrease in polarity from the environment, making 
molecules more lipophilic and increasing their membrane permeability (Kuhn et al. 2010), 
thus resulting in higher cytotoxicity and greater oxidative stress. With these thoughts in mind 
we decided to obtain the crystal structure of 1-(6-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-
yl)hexyl)guanidine hydrochloride (14.2H2O), which crystallised (from MeOH/Et2O/HCl/H2O) 
in the Triclinic P-1 space group (see Table S1 for details). The asymmetric unit in 14 
comprises one complete organic moiety, a single chloride counter anion and two waters of 
crystallisation. Upon close inspection of this structure, it is apparent that there are no 
intramolecular interactions of note in the solid state, presumably due (at least in part) to the 
absence of an OH group whose position in, for instance 11a-c and 15, might allow for the 
formation of H-bonded six membered rings when displaying a closed conformation. This 
inability to forge such intramolecular interactions may have significant ramifications with 
respect to lipophilicity and membrane permeability as indicated by the weaker CAT activity 
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and general response in 14. Although intramolecular exchanges are not observed in the crystal 
structure of 14, intermolecular interactions are prominent. The individual units in 14.2H2O are 
connected into 1D rows through multiple interactions involving the Cl
¯
 counter anions at the 
guanidine end of the moiety (N1(HN1B)
….
Cl1 = 2.81 Å and N2(HN2A)…Cl1 = 2.39 Å) and 
self-complementary H-bonds between juxtaposed uracil functional groups (N5(HN5)
…O2’ = 
1.91 Å (and s.e.)) at the other extremity (Figure 7). The chloride counter anions and waters of 
crystallisation partake in H-bonding with each other (O3(HO3A)
…
O4 = 1.87 Å; 
O4(HO4B)
…
Cl1 = 2.29 Å) as well as with the organic units in 14.2H2O at distances of (Å): 
2.32 (N4(HN4)
…
Cl), 2.03 (N3(HN3)
…
O3) and 2.10 (N2(HN2B)
…
O4), resulting in a 2D H-
bonded sheet formation. These counter anions and unbound water molecules also sit in-
between the planar sheets in 14.2H2O and are also held in position via various H-bonds 
(O3(HO3A)
…Cl1’ = 2.40 Å) and long contacts (C1(H2A)...Cl1’ = 2.81 Å) with each other as 
well as with neighboring organic units. 
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Figure 7. (a) The asymmetric unit in 14
.
2H2O. Dashed lines represent intermolecular H-
bonding at distances (Å): 2.10 (N2(HN2B)
…
O4); 2.29 (O4(HO4B)
…
Cl1) and 2.03 
(N3(HN3)
…
O3). (b) Two units of 14
.
2H2O interconnected along a 2D plane through 
numerous H-bonding interactions (as shown in (a)). (c) Side-view of the arrangement given in 
(b) highlighting the 2D H-bonded sheet-like array in 14
.
2H2O. 
 Altogether, these and previous findings suggest that all three, guanidine, uracil and 
hydroxyl groups are pivotal for CYN-induced toxicity in eukaryotic cells, including 
hepatocytes (Banker et al. 2001; Runnegar et al. 2002; Cartmell et al. 2017). This effect may 
be due to metabolites generated under CYN 1 metabolism, however, the exact process 
underlying the metabolic activation is still poorly understood. It has been speculated that the 
CYP1A subfamily of enzymes may be involved (Straser et al. 2011; Hercog et al. 2017; 
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Puerto et al. 2018), and as demonstrated by Humpage et al. (2005), cytotoxicity of CYN can 
be associated with CYP450-derived metabolites. As shown by Kittler et al. (2016) in HepaRG 
line, inhibition of CYP3A4 has led to decrease in CYN cytotoxicity but no metabolites were 
detected providing no evidence for phase I biotransformation. Further studies on phase II 
metabolism which can generate reactive and instable metabolites are required to fully assess 
the intracellular steps of CYN-induced toxicity.   
 
4. Conclusions 
 The present study is a continuation exploring a biological activity of synthetic 
analogues of CYN prepared in order to elucidate the structures involved in toxicity of 
naturally occurring compound. As indicated using experimental in vitro studies employing 
fish hepatocytes, whilst both guanidine and hydroxyl groups are key to CYN 1 toxicity, it is 
an interplay between these two that appears to magnify the observed cellular damage such as 
inducement of lipid peroxidation and apoptosis.  
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